Transforming growth factor-beta receptors and mannose 6- phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma

S. R. Sue, R. S. Chari, Feng Ming Kong, J. J. Mills, R. L. Fine, R. L. Jirtle, W. C. Meyers

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Objective: The authors examined the expression of transforming growth factor-beta receptor (TGF-βr) types I and II and the mannose 6- phosphate/insulin like growth factor-II receptor (M6-P/IGF-IIr) in human hepatocellular carcinoma (HCC). Summary Background Data: Transforming growth factor beta (TGF-β) is part of a superfamily of peptide signaling molecules that play an important role in modulating cell growth. It is secreted as a latent complex and therefore, must be activated to elicit a biological response. Bioactivation of the TGF-β complex is facilitated by binding to the M6-P/IGF-IIr. Once activated, TGF-β exerts its effects by binding to specific cell membrane TGF-β receptors. The loss of responsiveness of hepatocytes to TGF-β has been implicated in hepatocarcinogenesis and could result from a loss in the expression of either the TGF-β receptors or the M6-P/IGF-IIr. Methods: Human hepatocellular carcinomas and surrounding normal tissue were collected from operating room samples and snap-frozen in liquid nitrogen (n = 13). Tissues from two tumors were fixed in Omni-fix for sectioning and immunohistochemistry staining for the M6-P/IGF-IIr and TGF- β1. RNA was extracted from both normal and malignant liver tissue and analyzed using an RNase protection assay. SDS-PAGE of purified membrane hybridized with 125I-TGF-β1 and 125I-IGF-II was used to determine the TGF-β type I (TGF-βrI) and type II (TGF-βrII) receptors and MG-P/IGF-IIr protein levels, respectively. Gels were quantitated by phosphorimager, and a paired t test was used for statistical analysis. Results: In HCC, a 60% (p < 0.01) and 49% (p < 0.02) reduction in the mRNA levels for TβrI and TβrII, respectively, relative to the receptor levels in surrounding normal liver, was shown. A similar decrease in the receptor protein levels also was observed. The M6-P/IGF-IIr mRNA and protein levels were reduced in 7 of 11 hepatocellular Carcinomas. Immunohistochemical staining demonstrated an absence of intracellular TGF-β1 and reduced M6-P/IGF-IIr in the hepatocellular carcinoma cells. Conclusions: These results demonstrate that human HCCs have a significantly reduced expression of both the TGF-βrI- and TGF-βrII-signaling receptors for TGF-β. This may provide a selective growth advantage to the HCC by allowing them to escape the mito-inhibitory effects of activated TGF-β. Furthermore, in the subset of HCC in which the expression of the M6-P/IGF-IIr is downregulated, the bioactivation of TGF-β also may be impaired.

Original languageEnglish (US)
Pages (from-to)171-178
Number of pages8
JournalAnnals of Surgery
Volume222
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

IGF Type 2 Receptor
Transforming Growth Factor beta Receptors
Transforming Growth Factor beta
Hepatocellular Carcinoma
mannose-6-phosphate
Staining and Labeling
Transforming Growth Factor beta1
Messenger RNA
Proteins
Insulin-Like Growth Factor II
Liver
Operating Rooms
Ribonucleases
Growth
Polyacrylamide Gel Electrophoresis
Hepatocytes
Nitrogen
Down-Regulation
Gels
Immunohistochemistry

ASJC Scopus subject areas

  • Surgery

Cite this

Transforming growth factor-beta receptors and mannose 6- phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. / Sue, S. R.; Chari, R. S.; Kong, Feng Ming; Mills, J. J.; Fine, R. L.; Jirtle, R. L.; Meyers, W. C.

In: Annals of Surgery, Vol. 222, No. 2, 01.01.1995, p. 171-178.

Research output: Contribution to journalArticle

Sue, S. R. ; Chari, R. S. ; Kong, Feng Ming ; Mills, J. J. ; Fine, R. L. ; Jirtle, R. L. ; Meyers, W. C. / Transforming growth factor-beta receptors and mannose 6- phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. In: Annals of Surgery. 1995 ; Vol. 222, No. 2. pp. 171-178.
@article{bdb38397558149ffbf3f494c3a31d585,
title = "Transforming growth factor-beta receptors and mannose 6- phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma",
abstract = "Objective: The authors examined the expression of transforming growth factor-beta receptor (TGF-βr) types I and II and the mannose 6- phosphate/insulin like growth factor-II receptor (M6-P/IGF-IIr) in human hepatocellular carcinoma (HCC). Summary Background Data: Transforming growth factor beta (TGF-β) is part of a superfamily of peptide signaling molecules that play an important role in modulating cell growth. It is secreted as a latent complex and therefore, must be activated to elicit a biological response. Bioactivation of the TGF-β complex is facilitated by binding to the M6-P/IGF-IIr. Once activated, TGF-β exerts its effects by binding to specific cell membrane TGF-β receptors. The loss of responsiveness of hepatocytes to TGF-β has been implicated in hepatocarcinogenesis and could result from a loss in the expression of either the TGF-β receptors or the M6-P/IGF-IIr. Methods: Human hepatocellular carcinomas and surrounding normal tissue were collected from operating room samples and snap-frozen in liquid nitrogen (n = 13). Tissues from two tumors were fixed in Omni-fix for sectioning and immunohistochemistry staining for the M6-P/IGF-IIr and TGF- β1. RNA was extracted from both normal and malignant liver tissue and analyzed using an RNase protection assay. SDS-PAGE of purified membrane hybridized with 125I-TGF-β1 and 125I-IGF-II was used to determine the TGF-β type I (TGF-βrI) and type II (TGF-βrII) receptors and MG-P/IGF-IIr protein levels, respectively. Gels were quantitated by phosphorimager, and a paired t test was used for statistical analysis. Results: In HCC, a 60{\%} (p < 0.01) and 49{\%} (p < 0.02) reduction in the mRNA levels for TβrI and TβrII, respectively, relative to the receptor levels in surrounding normal liver, was shown. A similar decrease in the receptor protein levels also was observed. The M6-P/IGF-IIr mRNA and protein levels were reduced in 7 of 11 hepatocellular Carcinomas. Immunohistochemical staining demonstrated an absence of intracellular TGF-β1 and reduced M6-P/IGF-IIr in the hepatocellular carcinoma cells. Conclusions: These results demonstrate that human HCCs have a significantly reduced expression of both the TGF-βrI- and TGF-βrII-signaling receptors for TGF-β. This may provide a selective growth advantage to the HCC by allowing them to escape the mito-inhibitory effects of activated TGF-β. Furthermore, in the subset of HCC in which the expression of the M6-P/IGF-IIr is downregulated, the bioactivation of TGF-β also may be impaired.",
author = "Sue, {S. R.} and Chari, {R. S.} and Kong, {Feng Ming} and Mills, {J. J.} and Fine, {R. L.} and Jirtle, {R. L.} and Meyers, {W. C.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1097/00000658-199508000-00009",
language = "English (US)",
volume = "222",
pages = "171--178",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Transforming growth factor-beta receptors and mannose 6- phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma

AU - Sue, S. R.

AU - Chari, R. S.

AU - Kong, Feng Ming

AU - Mills, J. J.

AU - Fine, R. L.

AU - Jirtle, R. L.

AU - Meyers, W. C.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Objective: The authors examined the expression of transforming growth factor-beta receptor (TGF-βr) types I and II and the mannose 6- phosphate/insulin like growth factor-II receptor (M6-P/IGF-IIr) in human hepatocellular carcinoma (HCC). Summary Background Data: Transforming growth factor beta (TGF-β) is part of a superfamily of peptide signaling molecules that play an important role in modulating cell growth. It is secreted as a latent complex and therefore, must be activated to elicit a biological response. Bioactivation of the TGF-β complex is facilitated by binding to the M6-P/IGF-IIr. Once activated, TGF-β exerts its effects by binding to specific cell membrane TGF-β receptors. The loss of responsiveness of hepatocytes to TGF-β has been implicated in hepatocarcinogenesis and could result from a loss in the expression of either the TGF-β receptors or the M6-P/IGF-IIr. Methods: Human hepatocellular carcinomas and surrounding normal tissue were collected from operating room samples and snap-frozen in liquid nitrogen (n = 13). Tissues from two tumors were fixed in Omni-fix for sectioning and immunohistochemistry staining for the M6-P/IGF-IIr and TGF- β1. RNA was extracted from both normal and malignant liver tissue and analyzed using an RNase protection assay. SDS-PAGE of purified membrane hybridized with 125I-TGF-β1 and 125I-IGF-II was used to determine the TGF-β type I (TGF-βrI) and type II (TGF-βrII) receptors and MG-P/IGF-IIr protein levels, respectively. Gels were quantitated by phosphorimager, and a paired t test was used for statistical analysis. Results: In HCC, a 60% (p < 0.01) and 49% (p < 0.02) reduction in the mRNA levels for TβrI and TβrII, respectively, relative to the receptor levels in surrounding normal liver, was shown. A similar decrease in the receptor protein levels also was observed. The M6-P/IGF-IIr mRNA and protein levels were reduced in 7 of 11 hepatocellular Carcinomas. Immunohistochemical staining demonstrated an absence of intracellular TGF-β1 and reduced M6-P/IGF-IIr in the hepatocellular carcinoma cells. Conclusions: These results demonstrate that human HCCs have a significantly reduced expression of both the TGF-βrI- and TGF-βrII-signaling receptors for TGF-β. This may provide a selective growth advantage to the HCC by allowing them to escape the mito-inhibitory effects of activated TGF-β. Furthermore, in the subset of HCC in which the expression of the M6-P/IGF-IIr is downregulated, the bioactivation of TGF-β also may be impaired.

AB - Objective: The authors examined the expression of transforming growth factor-beta receptor (TGF-βr) types I and II and the mannose 6- phosphate/insulin like growth factor-II receptor (M6-P/IGF-IIr) in human hepatocellular carcinoma (HCC). Summary Background Data: Transforming growth factor beta (TGF-β) is part of a superfamily of peptide signaling molecules that play an important role in modulating cell growth. It is secreted as a latent complex and therefore, must be activated to elicit a biological response. Bioactivation of the TGF-β complex is facilitated by binding to the M6-P/IGF-IIr. Once activated, TGF-β exerts its effects by binding to specific cell membrane TGF-β receptors. The loss of responsiveness of hepatocytes to TGF-β has been implicated in hepatocarcinogenesis and could result from a loss in the expression of either the TGF-β receptors or the M6-P/IGF-IIr. Methods: Human hepatocellular carcinomas and surrounding normal tissue were collected from operating room samples and snap-frozen in liquid nitrogen (n = 13). Tissues from two tumors were fixed in Omni-fix for sectioning and immunohistochemistry staining for the M6-P/IGF-IIr and TGF- β1. RNA was extracted from both normal and malignant liver tissue and analyzed using an RNase protection assay. SDS-PAGE of purified membrane hybridized with 125I-TGF-β1 and 125I-IGF-II was used to determine the TGF-β type I (TGF-βrI) and type II (TGF-βrII) receptors and MG-P/IGF-IIr protein levels, respectively. Gels were quantitated by phosphorimager, and a paired t test was used for statistical analysis. Results: In HCC, a 60% (p < 0.01) and 49% (p < 0.02) reduction in the mRNA levels for TβrI and TβrII, respectively, relative to the receptor levels in surrounding normal liver, was shown. A similar decrease in the receptor protein levels also was observed. The M6-P/IGF-IIr mRNA and protein levels were reduced in 7 of 11 hepatocellular Carcinomas. Immunohistochemical staining demonstrated an absence of intracellular TGF-β1 and reduced M6-P/IGF-IIr in the hepatocellular carcinoma cells. Conclusions: These results demonstrate that human HCCs have a significantly reduced expression of both the TGF-βrI- and TGF-βrII-signaling receptors for TGF-β. This may provide a selective growth advantage to the HCC by allowing them to escape the mito-inhibitory effects of activated TGF-β. Furthermore, in the subset of HCC in which the expression of the M6-P/IGF-IIr is downregulated, the bioactivation of TGF-β also may be impaired.

UR - http://www.scopus.com/inward/record.url?scp=0029100622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029100622&partnerID=8YFLogxK

U2 - 10.1097/00000658-199508000-00009

DO - 10.1097/00000658-199508000-00009

M3 - Article

C2 - 7639583

AN - SCOPUS:0029100622

VL - 222

SP - 171

EP - 178

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 2

ER -